NO996265L - Behandling av diabetes med rosiglitazon og insulin - Google Patents

Behandling av diabetes med rosiglitazon og insulin

Info

Publication number
NO996265L
NO996265L NO996265A NO996265A NO996265L NO 996265 L NO996265 L NO 996265L NO 996265 A NO996265 A NO 996265A NO 996265 A NO996265 A NO 996265A NO 996265 L NO996265 L NO 996265L
Authority
NO
Norway
Prior art keywords
rosiglitazone
insulin
diabetes
treatment
Prior art date
Application number
NO996265A
Other languages
English (en)
Norwegian (no)
Other versions
NO996265D0 (no
Inventor
Stephen Alistair Smith
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO996265D0 publication Critical patent/NO996265D0/no
Publication of NO996265L publication Critical patent/NO996265L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
NO996265A 1997-06-18 1999-12-17 Behandling av diabetes med rosiglitazon og insulin NO996265L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9712866.4A GB9712866D0 (en) 1997-06-18 1997-06-18 Novel method of treatment
PCT/EP1998/003692 WO1998057636A1 (fr) 1997-06-18 1998-06-15 Nouvelle methode de traitement

Publications (2)

Publication Number Publication Date
NO996265D0 NO996265D0 (no) 1999-12-17
NO996265L true NO996265L (no) 1999-12-17

Family

ID=10814527

Family Applications (1)

Application Number Title Priority Date Filing Date
NO996265A NO996265L (no) 1997-06-18 1999-12-17 Behandling av diabetes med rosiglitazon og insulin

Country Status (30)

Country Link
EP (1) EP0999837A1 (fr)
JP (1) JP2002504138A (fr)
KR (1) KR20010013843A (fr)
CN (1) CN1133431C (fr)
AP (1) AP1287A (fr)
AR (2) AR015894A1 (fr)
AU (1) AU8216398A (fr)
BG (1) BG104059A (fr)
BR (1) BR9810444A (fr)
CA (1) CA2294141A1 (fr)
CO (1) CO4940454A1 (fr)
DZ (1) DZ2521A1 (fr)
EA (1) EA004800B1 (fr)
GB (1) GB9712866D0 (fr)
HU (1) HUP0003260A3 (fr)
ID (1) ID23951A (fr)
IL (1) IL133143A0 (fr)
IN (1) IN189723B (fr)
MA (1) MA26511A1 (fr)
NO (1) NO996265L (fr)
OA (1) OA11517A (fr)
PE (1) PE104499A1 (fr)
PL (1) PL343123A1 (fr)
SK (1) SK179399A3 (fr)
TR (1) TR199903095T2 (fr)
TW (1) TW587937B (fr)
UA (1) UA70299C2 (fr)
UY (1) UY25050A1 (fr)
WO (1) WO1998057636A1 (fr)
ZA (1) ZA985237B (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6291495B1 (en) * 1997-02-24 2001-09-18 Robert B. Rieveley Method and composition for the treatment of diabetes
TWI249401B (en) 1999-04-14 2006-02-21 Takeda Chemical Industries Ltd Agent for improving ketosis
BR0009934A (pt) 1999-04-23 2002-06-04 Smithkline Beecham Plc Produto farmacêutico
EP1133312B8 (fr) * 1999-06-21 2007-10-17 Eli Lilly And Company Utilisation combinee de thiazolidinediones et de peptide-1 de type glucagone et d'agonistes de ces derniers pour traiter diabetes non insulino-dependant.
WO2001000223A2 (fr) * 1999-06-25 2001-01-04 Minimed Inc. Therapie anti diabete a agents multiples
US6468507B1 (en) * 2000-05-01 2002-10-22 Aeropharm Technology, Inc. Non-aqueous aerosol formulation comprising rosiglitazone maleate, a non-aqueous carrier, and an amino acid stabilizer
GB0023970D0 (en) * 2000-09-29 2000-11-15 Smithkline Beecham Plc Novel pharmaceutical
AU2002248464A1 (en) 2001-02-21 2002-09-12 Medtronic Minimed, Inc. Stabilized insulin formulations
US6531461B1 (en) 2001-06-04 2003-03-11 Louis Obyo Obyo Nelson Medicament for the treatment of diabetes
WO2002100396A1 (fr) * 2001-06-07 2002-12-19 Wyeth Combinaison d'un inhibiteur de la ptpase et d'un agent thiazolidinedione
US6737401B2 (en) 2001-06-28 2004-05-18 Metronic Minimed, Inc. Methods of evaluating protein formulation stability and surfactant-stabilized insulin formulations derived therefrom
AU2003276234B2 (en) 2002-11-08 2007-04-19 F. Hoffmann-La Roche Ag Substituted 4-alkoxyoxazol derivatives as PPAR agonists
US7264813B2 (en) * 2003-09-24 2007-09-04 Nikken Sohonsha Corporation Therapeutic uses of Dunaliella powder
CN102389427A (zh) * 2011-10-10 2012-03-28 成都恒瑞制药有限公司 含有罗格列酮和盐酸西替利嗪的固体口服制剂

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995007694A1 (fr) * 1993-09-15 1995-03-23 Sankyo Company, Limited Utilisation de thiazolidinediones pour prevenir ou retarder l'apparition du diabete sucre non insulinodependant
WO1997005875A2 (fr) * 1995-08-10 1997-02-20 Warner-Lambert Company Procede permettant de reduire la quantite d'insuline exogene administree a un patient souffrant de diabete sucre non-insulinodependant
AU725998B2 (en) * 1995-09-18 2000-10-26 Eisai R&D Management Co., Ltd. Treating NIDDM with RXR agonists

Also Published As

Publication number Publication date
AU8216398A (en) 1999-01-04
NO996265D0 (no) 1999-12-17
WO1998057636A1 (fr) 1998-12-23
EA004800B1 (ru) 2004-08-26
AR012997A1 (es) 2000-11-22
KR20010013843A (ko) 2001-02-26
IL133143A0 (en) 2001-03-19
CN1133431C (zh) 2004-01-07
TW587937B (en) 2004-05-21
SK179399A3 (en) 2000-11-07
EP0999837A1 (fr) 2000-05-17
JP2002504138A (ja) 2002-02-05
AR015894A1 (es) 2001-05-30
CN1260715A (zh) 2000-07-19
OA11517A (en) 2004-02-04
IN189723B (fr) 2003-04-19
AP9901718A0 (en) 1999-12-31
UY25050A1 (es) 2000-09-29
DZ2521A1 (fr) 2003-02-08
ZA985237B (en) 2000-02-17
MA26511A1 (fr) 2004-12-20
TR199903095T2 (xx) 2000-08-21
AP1287A (en) 2004-06-26
BG104059A (en) 2000-10-31
HUP0003260A2 (hu) 2001-05-28
ID23951A (id) 2000-06-08
PL343123A1 (en) 2001-07-30
CA2294141A1 (fr) 1998-12-23
EA200000042A1 (ru) 2000-08-28
BR9810444A (pt) 2000-09-05
HUP0003260A3 (en) 2001-12-28
UA70299C2 (en) 2004-10-15
CO4940454A1 (es) 2000-07-24
PE104499A1 (es) 2000-01-13
GB9712866D0 (en) 1997-08-20

Similar Documents

Publication Publication Date Title
AP9901719A0 (en) Treatment of diabetes with thiazolidinedione and metormin
NO996265L (no) Behandling av diabetes med rosiglitazon og insulin
NO20000228L (no) Behandling av diabetes med tiazolidindion, insulin utskillende middel og diguanid
NO20000230D0 (no) Behandling av diabetes med tiazolidindion, insulin sekretagogue og <alfa>glukosidaseinhibitor
NO20000229L (no) Behandling av diabetes med tiazolidindion og sulfonylurea
NO996264L (no) Behandling av diabetes med tiazolidindion og sulfonylurea
NO996270D0 (no) Behandling av diabetes med tiazolidindion og <alfa>- glukosidaseinhibitor
HUP0002668A3 (en) Treatment of diabetes with thiazolidinedione and metformin
HUP0002669A3 (en) Treatment of diabetes with thiazolidinedione and sulphonylurea

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application